rss
Arch Dis Child Fetal Neonatal Ed 2008;93:F238-F239 doi:10.1136/adc.2007.121830
  • Short report

Antifungal prophylaxis for very low birthweight infants: UK national survey

  1. L Clerihew1,2,
  2. W McGuire1,2
  1. 1
    Ninewells Hospital and Medical School, Dundee, Scotland
  2. 2
    Australian National University, Canberra, Australia
  1. W McGuire, Centre for Newborn Care, Canberra Hospital, ACT 2606, Australia; william.mcguire{at}act.gov.au
  • Accepted 8 August 2007
  • Published Online First 3 September 2007

Abstract

In a UK-wide survey, 28% of neonatal units reported using systemic or topical/oral antifungal prophylaxis for very low birthweight infants. Systemic prophylaxis is targeted to extremely preterm infants with additional risk factors for invasive fungal infection. Currently, there seems to be sufficient variation in practice to undertake randomised trials of these interventions.

Footnotes

  • Competing interests: The authors have previously received an educational grant from Pfizer UK Ltd, a manufacturer of fluconazole. This company had no role in the collection, analysis and interpretation of data, or in the writing of the report or decision to submit for publication.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. adc.2007.121830v1
    2. 93/3/F238 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.